文献速递糖尿病

高免赔额健康计划与私营保险人群中2型糖尿病常规医疗参与度的关联:一项倾向评分匹配研究

Association Between High-Deductible Health Plans and Engagement in Routine Medical Care for Type 2 Diabetes in a Privately Insured Population: A Propensity Score-Matched Study.
PubMed 文献 · Diabetes Care · 2022-01-01

该回顾性队列纳入19,379例Kaiser Permanente北加州2型糖尿病患者(18-64岁),经倾向评分匹配比较6,801例高免赔额健康计划(HDHP)患者与无免赔额计划患者。HDHP患者初级保健就诊次数更少(4.25 vs 4.85次/人;P<0.001)、视网膜病变筛查率更低(49.9% vs 53.3%;P<0.001)、A1c和血压测量次数更少(46.7% vs 51.4%;P<0.001和93.2% vs 94.4%;P=0.004),用药依从性无显著差异(57.4% vs 58.6%;P=0.234)。作者认为HDHP似乎是2型糖尿病患者的障碍,降低了有自付费用就诊和无自付费用预防保健的参与度。

要点

  • HDHP患者初级保健就诊次数少于无免赔额计划患者(4.25 vs 4.85次/人;P<0.001)。
  • HDHP患者视网膜病变筛查率低于对照组(49.9% vs 53.3%;P<0.001)。
  • 两组用药依从性无显著差异(57.4% vs 58.6%;P=0.234)。

核心结论

  • HDHP似乎是2型糖尿病患者的障碍,降低了有自付费用就诊和无自付费用预防保健的参与度,可能因HDHP下费用分担复杂性增加,潜在导致重要临床测量监测减少。

研究设计与样本

  • 回顾性队列研究,纳入Kaiser Permanente北加州19,379例2型糖尿病患者(年龄18-64岁),其中6,801例HDHP患者经倾向评分匹配与无免赔额计划患者比较。

主要发现

  • HDHP患者初级保健办公室就诊次数少于无免赔额计划患者(4.25 vs 4.85次/人;P<0.001)。
  • HDHP患者视网膜病变筛查率低于对照组(49.9% vs 53.3%;P<0.001)。
  • HDHP患者A1c测量次数少于对照组(46.7% vs 51.4%;P<0.001)。
  • HDHP患者血压测量次数少于对照组(93.2% vs 94.4%;P=0.004)。
  • HDHP患者与无免赔额计划患者用药依从性无显著差异(57.4% vs 58.6%;P=0.234)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: High-deductible health plans (HDHPs) are increasingly more common but can be challenging for patients to navigate and may negatively affect care engagement for chronic conditions such as type 2 diabetes. We sought to understand how higher out-of-pocket costs affect participation in provider visits, medication adherence, and routine monitoring by patients with type 2 diabetes with an HDHP. RESEARCH DESIGN AND METHODS: In a retrospective cohort of 19,379 Kaiser Permanente Northern California patients with type 2 diabetes (age 18-64 years), 6,801 patients with an HDHP were compared with those with a no-deductible plan using propensity score matching. We evaluated the number of telephone and office visits with primary care, oral diabetic medication adherence, and rates of HbA1c testing, blood pressure monitoring, and retinopathy screening. RESULTS: Patients with an HDHP had fewer primary care office visits compared with patients with no deductible (4.25 vs. 4.85 visits per person; P < 0.001), less retinopathy screening (49.9% vs. 53.3%; P < 0.001), and fewer A1c and blood pressure measurements (46.7% vs. 51.4%; P < 0.001 and 93.2% vs. 94.4%; P = 0.004, respectively) compared with the control group. Medication adherence was not significantly different between patients with an HDHP and those with no deductible (57.4% vs. 58.6%; P = 0.234). CONCLUSIONS: HDHPs seem to be a barrier for patients with type 2 diabetes and reduce care participation in both visits with out-of-pocket costs and preventive care without out-of-pocket costs, possibly because of the increased complexity of cost sharing under an HDHP, potentially leading to decreased monitoring of important clinical measurements.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Wu YM, Huang J, Reed ME, et al. Association Between High-Deductible Health Plans and Engagement in Routine Medical Care for Type 2 Diabetes in a Privately Insured Population: A Propensity Score-Matched Study. Diabetes Care. 2022. PMID: 35290445. doi:10.2337/dc21-1885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。